Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction
PHASE4CompletedINTERVENTIONAL
Enrollment
12
Participants
Timeline
Start Date
September 30, 2002
Study Completion Date
December 31, 2004
Conditions
Acromegaly
Interventions
DRUG
Lanreotide Autogel and Octreotide LAR
Trial Locations (1)
5000
Department of Endocrinology, Odense University Hospital, Odense
All Listed Sponsors
lead
Odense University Hospital
OTHER
NCT00145405 - Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction | Biotech Hunter | Biotech Hunter